Schizophrenia Research
Volume 120, Issue 1 , Pages 184-190 , July 2010

Schizophrenia risk factors constitute general risk factors for psychiatric symptoms in the population

  • Elemi J. Breetvelt

      Affiliations

    • Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands
    • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands
    • Corresponding Author InformationCorresponding author. UMC-Utrecht, Heidelberglaan 100, 3584 CX Utrecht, PO. Box 85500, 3508 GA Utrecht, HP: B01.206, The Netherlands. Tel.: +31 88 75 56370; fax: +31 88 75 55509.
    • ,
  • Marco P.M. Boks

      Affiliations

    • Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands
    • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands
    • ,
  • Mattijs E. Numans

      Affiliations

    • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands
    • ,
  • Jean-Paul Selten

      Affiliations

    • GGZ Leiden en omstreken, The Netherlands
    • ,
  • Iris E.C. Sommer

      Affiliations

    • Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Diederick E. Grobbee

      Affiliations

    • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands
    • ,
  • René S. Kahn

      Affiliations

    • Rudolf Magnus Institute of Neuroscience, Department of Psychiatry, University Medical Center Utrecht, Utrecht, The Netherlands
    • ,
  • Mirjam I. Geerlings

      Affiliations

    • Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, The Netherlands

Received 17 November 2009 ,Revised 17 March 2010 ,Accepted 28 March 2010.

References 

  1. Aleman A, Kahn RS, Selten JP. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch. Gen. Psychiatry. 2003;60:565–571
  2. Arrindell WA, Ettema JHM. Dimensionele Structuur, Betrouwbaarheid en Validiteit van de Nederlandse Bewerking van de Symptom Checklist (SLC-90). Nederlands Tijdschrift Psychologie. 1981;43:381–387
  3. Boks MP, Leask S, Vermunt JK, Kahn RS. The structure of psychosis revisited: the role of mood symptoms. Schizophr. Res. 2007;93:178–185
  4. Boks MP, Hoogendoorn M, Jungerius BJ, Bakker SC, Sommer IE, Sinke RJ, et al. Do mood symptoms subdivide the schizophrenia phenotype? Association of the GMP6A gene with a depression subgroup. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2008;147B:707–711
  5. Buchanan and Carpenter WT junior, 2005. Schizophrenia and other psychotic disorders. In: Sadock BJ S.V. (Ed.), Kaplan and Sadock Comprehensive Textbook of psychiatry, Lippincott Williams & Wilkins, Philadelphia, PA, pp. 1329–1558
  6. Cantor-Graae E, Selten JP. Schizophrenia and migration: a meta-analysis and review. Am. J. Psychiatry. 2005;162:12–24
  7. CBS, Centraal Bureau voor de Statestiek, 2008. http://www.CBS.nl [accessed December 22 2008].
  8. Craig T, Hwang MY, Bromet EJ. Obsessive–compulsive and panic symptoms in patients with first-admission psychosis. Am. J. Psychiatry. 2002;159:592–598
  9. Davies G, Welham J, Chant D, Torrey EF, McGrath J. A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophr. Bull. 2003;29:587–593
  10. Dean K, Murray RM. Environmental risk factors for psychosis. Dialogues Clin Neurosci. 2005;7:69–80
  11. Derogatis LR, Cleary PA. Factorial invariance across gender for the primary symptom dimensions of the SCL-90. Br J Soc Clin Psychol. 1977;16:347–356
  12. Fearon P, Kirkbride JB, Morgan C, Dazzan P, Morgan K, Lloyd T, et al. Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol. Med. 2006;36:1541–1550
  13. Grobbee DE, Hoes AW, Verheij TJ, Schrijvers AJ, van Ameijden EJ, Numans ME. The Utrecht Health Project: optimization of routine healthcare data for research. Eur. J. Epidemiol. 2005;20:285–287
  14. Hanssen M, Peeters F, Krabbendam L, Radstake S, Verdoux H, Van OJ. How psychotic are individuals with non-psychotic disorders?. Soc. Psychiatry Psychiatr. Epidemiol. 2003;38:149–154
  15. Johns LC. Hallucinations in the general population. Curr Psychiatry Rep. 2005;7:162–167
  16. Johns LC, Van Os J. The continuity of psychotic experiences in the general population. Clin Psychol Rev. 2001;21:1125–1141
  17. Johns LC, Cannon M, Singleton N, Murray RM, Farrell M, Brugha T, et al. Prevalence and correlates of self-reported psychotic symptoms in the British population. Br. J. Psychiatry. 2004;185:298–305
  18. Kendler KS, Gallagher TJ, Abelson JM, Kessler RC. Lifetime prevalence, demographic risk factors, and diagnostic validity of nonaffective psychosis as assessed in a US community sample. The National Comorbidity Survey. Arch Gen Psychiatry. 1996;53:1022–1031
  19. Kendler KS, Prescott CA, Myers J, Neale MC. The structure of genetic and environmental risk factors for common psychiatric and substance use disorders in men and women. Arch. Gen. Psychiatry. 2003;60:929–937
  20. Kessler RC, Davis CG, Kendler KS. Childhood adversity and adult psychiatric disorder in the US National Comorbidity Survey. Psychol. Med. 1997;27:1101–1119
  21. Krabbendam L, Myin-Germeys I, Hanssen M, de GR, Vollebergh W, Bak M, et al. Development of depressed mood predicts onset of psychotic disorder in individuals who report hallucinatory experiences. Br. J. Clin. Psychol. 2005;44:113–125
  22. Maric N, Krabbendam L, Vollebergh W, de GR, Van Os J. Sex differences in symptoms of psychosis in a non-selected, general population sample. Schizophr. Res. 2003;63:89–95
  23. Molenaar EA, van Ameijden EJ, Grobbee DE, Numans ME. Comparison of routine care self-reported and biometrical data on hypertension and diabetes: results of the Utrecht Health Project. Eur J Public Health. 2007;17(2):199–205
  24. Rössler W, Riecher-Rossler A, Angst J, Murray R, Gamma A, Eich D, et al. Psychotic experiences in the general population: a twenty-year prospective community study. Schizophr. Res. 2007;92:1–14
  25. Schmitz N, Hartkamp N, Franke GH. Assessing clinically significant change: application to the SCL-90-R. Psychol. Rep. 2000;86:263–274
  26. Stefanis NC, Hanssen M, Smirnis NK, Avramopoulos DA, Evdokimidis IK, Stefanis CN, et al. Evidence that three dimensions of psychosis have a distribution in the general population. Psychol. Med. 2002;32:347–358
  27. Tien AY. Distributions of hallucinations in the population. Soc. Psychiatry Psychiatr. Epidemiol. 1991;26:287–292
  28. van der Heijden GJ, Donders AR, Stijnen T, Moons KG. Imputation of missing values is superior to complete case analysis and the missing-indicator method in multivariable diagnostic research: a clinical example. J Clin Epidemiol. 2006;59:1102–1109
  29. Van Os J, Hanssen M, Bijl RV, Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population?. Schizophr. Res. 2000;45:11–20
  30. Vanheusden K, Mulder CL, van der EJ, Selten JP, van Lenthe FJ, Verhulst FC, et al. Associations between ethnicity and self-reported hallucinations in a population sample of young adults in The Netherlands. Psychol. Med. 2008;38:1095–1102
  31. Verdoux H, Van Os J. Psychotic symptoms in non-clinical populations and the continuum of psychosis. Schizophr. Res. 2002;54:59–65

PII: S0920-9964(10)01204-1

doi: 10.1016/j.schres.2010.03.033

Schizophrenia Research
Volume 120, Issue 1 , Pages 184-190 , July 2010

Article Tools

* Image Usage & Resolution